Products are sold per kit, with each kit containing 10 vials. Prices listed are for each kit.

Contains: 
4.8mg per vial x 10 vials

Product Name:  Cagrilintide + Semaglutide

Description:
Cagri+Sema 4.8mg combines 2.4mg of Cagrilintide and 2.4mg of Semaglutide to deliver a dual-action approach to appetite control, weight management, and metabolic support. Cagrilintide mimics the amylin hormone to promote satiety and delay gastric emptying, while Semaglutide, a GLP-1 receptor agonist, reduces hunger and enhances insulin function.
This synergistic blend is being closely studied for its potential to accelerate fat loss, improve glycemic control, and reduce food intake more effectively than either compound alone.

Uses & Benefits:

• Dual Appetite Control: Targets hunger from two different hormonal pathways for stronger satiety.

• Supports Fat Loss: Helps reduce calorie intake and supports consistent weight reduction.

• Blood Sugar Regulation: Semaglutide aids insulin sensitivity and glucose stability.

• Improved Metabolic Markers: May benefit lipid levels, inflammation, and insulin resistance.

• Fewer Cravings, Smaller Meals: Slows digestion and increases meal satisfaction.

Note: For research purposes only. Not intended for human use.